CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-0.76%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.55B
AUM Growth
+$7.55B
(-5.7%)
Cap. Flow
-$246M
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
20.77%
Holding
870
New
59
Increased
344
Reduced
256
Closed
125
Top Buys
| 1 |
Nike
NKE
|
$27.8M |
| 2 |
AbbVie
ABBV
|
$24.2M |
| 3 |
Waste Management
WM
|
$18.7M |
| 4 |
Gilead Sciences
GILD
|
$17.2M |
| 5 |
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
|
$16.6M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$70.2M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$45.8M |
| 3 |
Biogen
BIIB
|
$43.3M |
| 4 |
Prudential Financial
PRU
|
$25.9M |
| 5 |
Meta Platforms (Facebook)
META
|
$23.3M |
Sector Composition
| 1 | Healthcare | 31.81% |
| 2 | Technology | 18.29% |
| 3 | Financials | 10.05% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
51
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $29M | 0.38% |
1,228,000
+50,000
| +4% | +$1.18M |
|
|
52
Nike
NKE
$110B
| $27.8M | 0.37% |
+295,763
| New | +$27.8M |
|
53
Union Pacific
UNP
$132B
| $26.4M | 0.35% |
163,188
+14,919
| +10% | +$2.42M |
|
54
Emerson Electric
EMR
$72.9B
| $25.6M | 0.34% |
382,028
+43,374
| +13% | +$2.9M |
|
55
Bio-Techne
TECH
$8.3B
| $25.4M | 0.34% |
129,857
+21,840
| +20% | +$4.27M |
|
56
Keysight
KEYS
$28.4B
| $25.4M | 0.34% |
260,897
-23,892
| -8% | -$2.32M |
|
57
Allstate
ALL
$53.9B
| $25.1M | 0.33% |
231,247
+37,129
| +19% | +$4.04M |
|
58
Intuitive Surgical
ISRG
$158B
| $24.4M | 0.32% |
45,235
+23,499
| +108% | +$12.7M |
|
59
BioMarin Pharmaceuticals
BMRN
$11.3B
| $24.2M | 0.32% |
359,520
-86,410
| -19% | -$5.82M |
|
60
Analog Devices
ADI
$120B
| $24M | 0.32% |
214,821
-19,816
| -8% | -$2.21M |
|
61
Intel
INTC
$105B
| $23.4M | 0.31% |
454,549
-41,564
| -8% | -$2.14M |
|
62
PTC Therapeutics
PTCT
$4.41B
| $23.4M | 0.31% |
690,523
+50,000
| +8% | +$1.69M |
|
63
Texas Instruments
TXN
$178B
| $23.2M | 0.31% |
179,842
-70,542
| -28% | -$9.12M |
|
|
ANSS
64
DELISTED
Ansys
ANSS
| $22.9M | 0.3% |
103,557
+37,901
| +58% | +$8.39M |
|
65
Bio-Rad Laboratories Class A
BIO
$7.8B
| $22.8M | 0.3% |
68,450
+23,660
| +53% | +$7.87M |
|
|
66
Prudential Financial
PRU
$37.8B
| – | – |
-238,677
| Closed | -$25.9M |
|
67
Arrowhead Research
ARWR
$3.84B
| $22.1M | 0.29% |
784,000
+255,000
| +48% | +$7.19M |
|
68
Incyte
INCY
$17B
| $21.8M | 0.29% |
294,191
-100,305
| -25% | -$7.45M |
|
|
XLRN
69
DELISTED
Acceleron Pharma Inc.
XLRN
| $21.8M | 0.29% |
551,500
+169,552
| +44% | +$6.7M |
|
|
ONC
70
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $21.5M | 0.29% |
175,752
-58,000
| -25% | -$7.1M |
|
71
Sherwin-Williams
SHW
$90.5B
| $21.5M | 0.28% |
39,046
-15,883
| -29% | -$8.73M |
|
|
WBC
72
DELISTED
WABCO HOLDINGS INC.
WBC
| $21M | 0.28% |
157,305
+66,365
| +73% | +$8.88M |
|
73
PTC
PTC
$25.4B
| $20.5M | 0.27% |
301,153
+73,188
| +32% | +$4.99M |
|
74
Wells Fargo
WFC
$258B
| $20M | 0.26% |
395,942
+239,386
| +153% | +$12.1M |
|
|
SAGE
75
DELISTED
Sage Therapeutics
SAGE
| $19.5M | 0.26% |
139,300
+21,000
| +18% | +$2.95M |
|